Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | RA Capital Management, L.P. | 0 0.000% | -3,363,605 (Position Closed) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | CITADEL ADVISORS LLC | 2,421,024 7.100% | 7,143 (+0.30%) | Filing History |
| 2021-02-12 4:19 pm Sale | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | REGENXBIO Inc. RGNX | 0 0.000% | -2,030,000 (Position Closed) | Filing History |
| 2021-02-12 4:06 pm Sale | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital, LLC | 0 0.000% | -2,248,306 (Position Closed) | Filing History |
| 2021-01-29 4:15 pm Unchanged | 2021-01-20 | 13G | PREVAIL THERAPEUTICS INC PRVL | JNE Partners LLP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-01-28 8:30 pm Sale | 2021-01-22 | 13D | PREVAIL THERAPEUTICS INC PRVL | ORBIMED ADVISORS LLC | 0 0.000% | -13,822,463 (Position Closed) | Filing History |
| 2020-12-22 08:49 am Purchase | 2020-12-14 | 13D | PREVAIL THERAPEUTICS INC PRVL | ELI LILLY & Co LLY | 18,858,511 53.300% | 18,858,511 (New Position) | Filing History |
| 2020-10-08 4:02 pm Purchase | 2020-09-28 | 13G | PREVAIL THERAPEUTICS INC PRVL | CITADEL ADVISORS LLC | 2,413,881 7.100% | 2,413,881 (New Position) | Filing History |